Lantheus Holdings (LNTH) Treasury Shares (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Treasury Shares of $477.4 million for Q1 2026, up 172.82% year-over-year from $175.0 million in Q1 2025, and little changed quarter-over-quarter from $477.4 million in Q4 2025.
Lantheus Holdings (LNTH) Treasury Shares (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Treasury Shares for 6 consecutive years, with $477.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 172.82% year-over-year to $477.4 million; the TTM figure through Mar 2026 stood at $477.4 million (up 172.82% YoY), while the FY2025 annual figure was $477.4 million, up 172.82% from the prior year.
- Treasury Shares was little changed at $477.4 million in Q1 2026 per LNTH's latest filing, from $477.4 million in the prior quarter.
- Across five years, Treasury Shares topped out at $7.2 million in Q4 2025 and bottomed at $1339.0 in Q4 2022.
- Historically, Treasury Shares has averaged $2.3 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2023 — Treasury Shares changed 0.0% — and 2025, when it surged 401.94%.
- Lantheus Holdings' Treasury Shares stood at $75.0 million in 2022, then changed by 0.0% to $75.0 million in 2023, then soared by 133.33% to $175.0 million in 2024, then surged by 172.82% to $477.4 million in 2025, then changed by 0.0% to $477.4 million in 2026.
- Business Quant data shows LNTH's Treasury Shares at $477.4 million in Q1 2026, $477.4 million in Q4 2025, and $376.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 477.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.24 Mn |
| Jun 30, 2026 | 7.24 Mn |
| Jun 30, 2026 | 477.44 Mn |
| Jun 30, 2026 | 477.44 Mn |
| Mar 31, 2026 | 7.24 Mn |
| Mar 31, 2026 | 7.24 Mn |
| Mar 31, 2026 | 477.44 Mn |
| Mar 31, 2026 | 477.44 Mn |
| Dec 31, 2025 | 7.24 Mn |
| Dec 31, 2025 | 7.24 Mn |
| Dec 31, 2025 | 477.44 Mn |
| Dec 31, 2025 | 477.44 Mn |
| Sep 30, 2025 | 5.47 Mn |
| Sep 30, 2025 | 5.47 Mn |
| Sep 30, 2025 | 376.46 Mn |
| Sep 30, 2025 | 376.46 Mn |
| Jun 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 275.00 Mn |
| Jun 30, 2025 | 275.00 Mn |